NRX101 Glx Biomarker Validation Study

NCT03402152 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression
Suicidal Ideation

Interventions

DRUG: NRX-101
DRUG: Lurasidone HCl
DRUG: Placebo

Sponsor

NeuroRx, Inc.

Collaborators

[object Object]